|
||
Comment |
Correspondence to: Mark Noble, Huntsman Cancer Institute, Rm. 4280, Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112. Tel:(801) 585-7167 Fax:(801) 585-7120 E-mail:mark.noble{at}hci.utah.edu.
This article has been cited by other articles:
|
|